WO2026104594 - BIOSENSOR
National phase entry is expected:
Publication Number
WO/2026/104594
Publication Date
21.05.2026
International Application No.
PCT/EP2025/083013
International Filing Date
14.11.2025
Title **
[English]
BIOSENSOR
[French]
BIOCAPTEUR
Applicants **
ETH ZURICH
Inventors
DEMELLO, Andrew
RICHARDS, Daniel
PARTINGTON, Yukina
Priority Data
24213179.5
15.11.2024
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2338 | |
| EPO | Filing, Examination, Granting | 11329 | |
| Japan | Filing, Examination, Granting | 2336 | |
| South Korea | Filing, Examination, Granting | 2313 | |
| USA | Filing, Examination, Granting | 7140 |
Total:
25,456
Contact Us
Abstract[English]
A DNA sequence and a synthetic gene circuit (SGC) comprising the same for detecting a DNA or RNA nucleotide trigger sequence, associated detection systems, methods for detecting the DNA or RNA nucleotide trigger sequence as well as further proteins of interest and associated uses.[French]
L'invention concerne une séquence d'ADN et un circuit génique synthétique (SGC) la comprenant pour détecter une séquence de déclenchement nucléotidique d'ADN ou d'ARN, des systèmes de détection associés, des procédés de détection de la séquence de déclenchement nucléotidique d'ADN ou d'ARN ainsi que d'autres protéines d'intérêt et des utilisations associées.